Form 4: U.S. Physical Therapy Director Kathleen Gilmartin Buys 2,000 Shares

Kathleen Gilmartin, a director of U.S. Physical Therapy, recently purchased 2,000 shares of the company's common stock at an average price of $86.09.

Summary

• On September 3, 2024, Kathleen A. Gilmartin, a director of U.S. Physical Therapy Inc., purchased 2,000 shares of common stock.
• The purchase price averaged $86.09 per share, with individual transactions ranging from $85.93 to $86.17.
• Following the transaction, Gilmartin directly owns 18,904 shares, which includes 1,068 shares of restricted stock granted under the company's Amended and Restated 2003 Stock Incentive Plan.
• Restrictions on 356 of these shares will lapse on October 1, 2024, January 1, 2025, and April 1, 2025, contingent on her continued service on the Board of Directors.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but the purchase is relatively small and doesn't provide a strong signal.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider transactions are closely monitored as they can provide insights into management's perspective on the company's valuation and future performance relative to its peers in the physical therapy industry.

Comparison to Industry Standards

• Comparing insider buying activity at U.S. Physical Therapy to similar companies like ATI Physical Therapy or Select Medical can provide context on whether this purchase is an isolated event or part of a broader trend.
• Generally, insider buying is viewed positively, but its significance depends on the size of the purchase relative to the insider's existing holdings and the company's market capitalization.

Stakeholder Impact

• The purchase could have a minor positive impact on shareholder sentiment.

Key Dates